GAM Holding’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,000
| Closed | -$275K | – | 154 |
|
|
2024
Q2 | $275K | Buy |
+3,000
| New | +$278K | 0.02% | 151 |
|
|
2023
Q4 | – | Sell |
-4,550
| Closed | -$425K | – | 164 |
|
|
2023
Q3 | $425K | Buy |
4,550
+1,250
| +38% | +$116K | 0.03% | 162 |
|
|
2023
Q2 | $302K | Buy |
+3,300
| New | +$271K | 0.02% | 185 |
|
|
2022
Q3 | – | Sell |
-6,346
| Closed | -$667K | – | 227 |
|
|
2022
Q2 | $667K | Buy |
6,346
+295
| +5% | +$37.7K | 0.04% | 199 |
|
|
2022
Q1 | $1.04M | Sell |
6,051
-1,744
| -22% | -$261K | 0.05% | 198 |
|
|
2021
Q4 | $1.26M | Sell |
7,795
-58
| -0.7% | -$9.32K | 0.06% | 190 |
|
|
2021
Q3 | $1.17M | Sell |
7,853
-11
| -0.1% | -$2.29K | 0.05% | 197 |
|
|
2021
Q2 | $1.93M | Buy |
7,864
+1,237
| +19% | +$325K | 0.08% | 194 |
|
|
2021
Q1 | $1.75M | Buy |
6,627
+2,188
| +49% | +$617K | 0.08% | 206 |
|
|
2020
Q4 | $1.3M | Sell |
4,439
-43
| -1% | -$11K | 0.08% | 180 |
|
|
2020
Q3 | $1.06M | Sell |
4,482
-103
| -2% | -$23.4K | 0.06% | 239 |
|
|
2020
Q2 | $910K | Sell |
4,585
-389
| -8% | -$72.6K | 0.06% | 247 |
|
|
2020
Q1 | $913K | Buy |
4,974
+163
| +3% | +$29K | 0.06% | 237 |
|
|
2019
Q4 | $803K | Sell |
4,811
-1,686
| -26% | -$251K | 0.04% | 295 |
|
|
2019
Q3 | $851K | Buy |
6,497
+4,019
| +162% | +$523K | 0.04% | 428 |
|
|
2019
Q2 | $301K | Sell |
2,478
-920
| -27% | -$109K | 0.01% | 775 |
|
|
2019
Q1 | $419K | Sell |
3,398
-1,478
| -30% | -$185K | 0.02% | 660 |
|
|
2018
Q4 | $560K | Sell |
4,876
-4,690
| -49% | -$553K | 0.03% | 511 |
|
|
2018
Q3 | $1.2M | Buy |
9,566
+1,704
| +22% | +$188K | 0.04% | 414 |
|
|
2018
Q2 | $672K | Buy |
+7,862
| New | +$577K | 0.02% | 580 |
|
|
2015
Q2 | – | Sell |
-30,000
| Closed | -$803K | – | 1139 |
|
|
2015
Q1 | $803K | Hold |
30,000
| – | – | 0.01% | 772 |
|
|
2014
Q4 | $881K | Sell |
30,000
-20,000
| -40% | -$494K | 0.01% | 738 |
|
|
2014
Q3 | $1.01M | Hold |
50,000
| – | – | 0.01% | 709 |
|
|
2014
Q2 | $837K | Hold |
50,000
| – | – | 0.01% | 739 |
|
|
2014
Q1 | $745K | Buy |
50,000
+20,000
| +67% | +$308K | 0.01% | 742 |
|
|
2013
Q4 | $439K | Hold |
30,000
| – | – | 0.01% | 707 |
|
|
2013
Q3 | $517K | Sell |
30,000
-40,000
| -57% | -$593K | 0.01% | 800 |
|
|
2013
Q2 | $813K | Buy |
+70,000
| New | +$802K | 0.02% | 557 |
|
Other funds holding AMED
FCM
WCMNY
PCM
AAM
GAM Holding's AMED Position: Q3 2024 in Review
GAM Holding sold out of Amedisys (AMED) in Q3 2024, closing a stake of 3,000 shares — an estimated $275K sold.
GAM Holding first reported a position in AMED in Q2 2013 and held it in 28 quarters. The position peaked at $1.93M in Q2 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.
- GAM Holding reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
- GAM Holding sold 3,000 Amedisys shares in Q3 2024, an estimated $275K.
- GAM Holding first reported a position in Amedisys in Q2 2013 and held it in 28 quarters.
- GAM Holding's Amedisys position peaked at $1.93M in Q2 2021.
- 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.
Based on GAM Holding's 13F filing for Q3 2024, filed 22 Oct 2024.